Cost-effectiveness of an adjuvanted recombinant zoster vaccine in adults with inflammatory bowel disease. Caldera F, Spaulding AC, Borah B, Moriarty J, et al. Aliment Pharmacol Ther 2023 Mar 10. doi: 10.1111/apt.17454.

Read + Share

Amedeo Smart

Independent Medical Education

Caldera F, Spaulding AC, Borah B, Moriarty J, et al. Cost-effectiveness of an adjuvanted recombinant zoster vaccine in adults with inflammatory bowel disease. Aliment Pharmacol Ther 2023 Mar 10. doi: 10.1111/apt.17454.
PMID: 36896952